Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction
Authors:
- Chien-Jung LinCLChien-Jung Lin
- Kuo-Hsing ChenKCKuo-Hsing Chen
- Jiann-Chun WuJWJiann-Chun Wu
- Shih-Horng HuangSHShih-Horng Huang
- Seu-Mei WangSWSeu-Mei Wang
- 27 April 2006
- journal article
- Published by Wiley in FEBS Letters
- Vol. 580 (13) , 3042-3050
Abstract
Tumor‐associated macrophages play an important role in tumor progression, but whether they exert a tumor‐progressive effect remains controversial. Here, we demonstrated that activated macrophage‐conditioned medium (AMCM) obtained from RAW macrophages (RAW/AMCM) induced epithelial‐mesenchymal transition (EMT) and stimulated the migratory and invasive activities of HepG2 cells, whereas control conditioned media had no effect. Epithelial‐cadherin (E‐cadherin) and β‐catenin staining patterns were altered at the adherens junctions by RAW/AMCM treatment, with an approximately 50% decrease in E‐cadherin and β‐catenin in the cell membrane. Importantly, levels of β‐catenin‐associated E‐cadherin were also decreased. Following RAW/AMCM treatment, enhanced activation of c‐Src was seen prior to increased tyrosine phosphorylation of β‐catenin, and this led to the destabilization of adherens junctions. Pretreatment of HepG2 cells with the Src kinase inhibitor, PP2, completely abolished the effects of RAW/AMCM on the EMT, migration, invasion, and expression and association of E‐cadherin and β‐catenin. AMCMs obtained from human THP‐1 monocytes and mouse peritoneal macrophages also caused disassembly of the adherens junctions and migration of HepG2 cells. Furthermore, inhibition of the epidermal growth factor receptor (EGFR) with gefitinib partially prevented the downregulation of E‐cadherin and β‐catenin at the adherens junctions and migration behavior induced by RAW/AMCM. Our results suggest that activated macrophages have a tumor‐progressive effect on HepG2 cells which involves the c‐Src‐ and EGFR‐dependent signaling cascades.Keywords
This publication has 41 references indexed in Scilit:
- Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiationBiochemical and Biophysical Research Communications, 2006
- NF-κB: linking inflammation and immunity to cancer development and progressionNature Reviews Immunology, 2005
- NF-κB functions as a tumour promoter in inflammation-associated cancerNature, 2004
- Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literatureJournal of Cancer Research and Clinical Oncology, 2004
- A renaissance for SRCNature Reviews Cancer, 2004
- p120 Catenin-Associated Fer and Fyn Tyrosine Kinases Regulate β-Catenin Tyr-142 Phosphorylation and β-Catenin-α-Catenin InteractionMolecular and Cellular Biology, 2003
- Inflammation and cancerNature, 2002
- Paracrine cyclooxygenase-2-mediated signalling by macrophages promotes tumorigenic progression of intestinal epithelial cellsOncogene, 2002
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapiesThe Journal of Pathology, 2002
- The E-cadherin–catenin complex in tumour metastasisEuropean Journal of Cancer, 2000